Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 12 of 12 publications.

Crowe HM, Wesselink AK, Wise LA, Jick SS, Rothman KJ, Mikkelsen EM, Sorensen HT, Hatch EE. Pre-pregnancy migraine diagnosis, medication use, and spontaneous abortion: a prospective cohort study. J. Headache Pain. 2022 Dec 20;23(1):162. doi: 10.1186/s10194-022-01533-6

Ungar R, Wu L, MacLeod S, Tkatch R, Albright L, Schaeffer J, Wicker E. The efficacy and utilization of an online mindfulness intervention on lonely older adults. J Behav Health. 2021 Sep 20;9(2):1-8. doi: 10.33425/2832-4579/21027

Koziel M, Teutsch C, Bayer V, Lu S, Gurusamy VK, Halperin JL, Rothman KJ, Diener HC, Ma CS, Huisman MV, Lip GYH, GLORIA‐AF Investigators. Changes in anticoagulant prescription patterns over time for patients with atrial fibrillation around the world. J Arrhythm. 2021 Jul 10;37(4):990-1006. doi: 10.1002/joa3.12588

MacLeod S, Kraemer S, Tkatch R, Fellows A, Albright L, McGinn M, Schaeffer J, Yeh CS. Defining the personal determinants of health for older adults. J Behav Health. 2021 Jan;10(1):295-334. doi: 10.33425/2832-4579/21023

Ma C, Riou Franca L, Lu S, Diener H-C, Dubner SJ, Halperin JL, Li Q, Paquette M, Teutsch C, Huisman MV, Lip GYH, Rothman KJ. Stroke prevention in atrial fibrillation changes after dabigatran availability in China: the GLORIA‐AF registry. J Arrhythm. 2020 Mar 10;36(3):408-16. doi: 10.1002/joa3.12321

Fernandez MM, Wang J, Ye X, Kwong WJ, Sherif B, Hogue S, Sherrill B. Systematic review and network meta-analysis of the relative efficacy and safety of edoxaban versus other nonvitamin K antagonist oral anticoagulants among patients with nonvalvular atrial fibrillation and CHADS2 score slanted greater than or equal to 2. SAGE Open Med. 2015 Dec. doi: 10.1177/2050312115613350

Morelli X, Foraster M, Aguilera I, Basagana X, Corradi E, Deltell A, Ducret-Stich R, Phuleria H, Ragettli MS, Rivera M, Thomasson A, Kunzli N, Slama R. Short-term associations between traffic-related noise, particle number and traffic flow in three European citie. Atmos Environ. 2015 Feb;103:25-33. doi: 10.1016/j.atmosenv.2014.12.012

Ragettli MS, Ducret-Stich RE, Foraster M, Morelli X, Aguilera I, Basagana X, Corradi E, Ineichen A, Tsai M, Probst-Hensch N, Rivera M, Slama R, Kunzli N, Phuleria HC. Spatio-temporal variation of urban ultrafine particle number concentrations. Atmos Environ. 2014 Oct;96:275-83. doi: 10.1016/j.atmosenv.2014.07.049

Matharu M, Pascual J, Nilsson Remahl I, Odom D, Gutierrez L, Andrews E, Largent J, Johannes C. EHMTI-0192. Onabotulinumtoxina prophylaxis in chronic migraine utilization and patient characteristics: observational study in the European Union. Poster presented at the 4th European Headache and Migraine Trust International Congress 2014; September 2014. Copenhagen, Denmark. [abstract] J. Headache Pain. 2014 Sep 18; 15(Suppl 1):G24. doi: 10.1186/1129-2377-15-S1-G24

Aguilera I, Basagana X, Pay MT, Agis D, Bouso L, Foraster M, Rivera M, Baldasano JM, Kunzli N. Evaluation of the CALIOPE air quality forecasting system for epidemiological research: the example of NO2 in the province of Girona (Spain). Atmos Environ. 2013 Jun;72:134-41. doi: 10.1016/j.atmosenv.2013.02.035

Rivera M, Basagana X, Aguilera I, Agis D, Bouso L, Foraster M, Medina-Ramon M, Pey J, Kunzli N, Hoek G. Spatial distribution of ultrafine particles in urban settings: a land use regression model. Atmos Environ. 2012 Jul;54:657-66. doi: 10.1016/j.atmosenv.2012.01.058

Basagana X, Rivera M, Aguilera I, Agis D, Bouso L, Elosua R, Foraster M, de Nazelle A, Nieuwenhuijsen M, Vila J, Kunzli N. Effect of the number of measurement sites on land use regression models in estimating local air pollution. Atmos Environ. 2012 Jul;54:634-42. doi: 10.1016/j.atmosenv.2012.01.064